Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine microspheres in early Parkinson's disease
NCT04455555Phase 3Completed
- Sponsor
- Peking University Third Hospital
- Start
- Aug 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rotigotine in Parkinson's disease (PD), sponsored by Peking University Third Hospital. Started Aug 2018; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04455555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04455555.